Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Conestat alfa by Pharming Group for Acute Ischemic Stroke: Likelihood of Approval
Conestat alfa is under clinical development by Pharming Group and currently in Phase II for Acute Ischemic Stroke. According to...